Inflammatory Scores: Comparison and Utility in HCC Patients Undergoing Transarterial Chemoembolization in a North American Cohort

Young S., Cam İ., Gencturk M., Rubin N., D'souza D., Flanagan S., ...Daha Fazla

JOURNAL OF HEPATOCELLULAR CARCINOMA, cilt.8, ss.1513-1524, 2021 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 8
  • Basım Tarihi: 2021
  • Doi Numarası: 10.2147/jhc.s335183
  • Dergi Adı: JOURNAL OF HEPATOCELLULAR CARCINOMA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
  • Sayfa Sayıları: ss.1513-1524
  • Anahtar Kelimeler: hepatocellular carcinoma, chemoembolization, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, aspartate-aminotransferase-to-lymphocyte ratio, systemic-inflammation index, TO-LYMPHOCYTE RATIO, UNRESECTABLE HEPATOCELLULAR-CARCINOMA, ASPARTATE-AMINOTRANSFERASE, NEUTROPHIL, SURVIVAL, INDEX, PREDICT, RISK
  • Kocaeli Üniversitesi Adresli: Hayır

Özet

Background: The purpose of this study is to determine and compare the ability of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), aspartate-aminotransferase-to-lymphocyte ratio (ALRI), systemic-inflammation index (SII) and lymphocyte count to predict oncologic outcomes in hepatocellular carcinoma (HCC) patients undergoing transarterial chemoembolization (TACE).